Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
DOI
 |
|
Open Access Green as soon as Postprint is submitted to ZB.
Cost-effectiveness of diagnostic interventions: Non-small cell lung cancer.
Onkologe 16, 992-1002 (2010)
The present article is intended as an introduction to health economic evaluation as well as a review of economic evaluations of positron emission tomography (PET and PET/CT) in the diagnosis and management of non-small cell lung cancer. Furthermore, the transferability of the results of economic evaluations in other countries to the German health care context is assessed. With the help of a literature search 13 full health economic evaluations of staging (12 studies) and follow-up (1 study) of non-small cell lung cancer were identified. The primary health benefit measure was life years gained or quality-adjusted life years gained. All of these evaluations were based on modeling studies. Due to differences in assumptions and methodological heterogeneity, the incremental cost-effectiveness ratios varied widely. Because of the complexity of the diagnostic and therapeutic process, the transferability of international study results to the German situation is limited. The cost-effectiveness of PET for other management decisions in non-small cell lung cancer (e.g. radiotherapy planning) is still to be assessed.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
18F-Fluorodeoxyglucose; Positron-emission tomography; Computed tomography; Non-small cell lung cancer; Cost effectiveness; POSITRON-EMISSION-TOMOGRAPHY; FDG-PET; TECHNOLOGY-ASSESSMENT; PATIENT-MANAGEMENT; IMPACT; CARCINOMA; ONCOLOGY; RECOMMENDATIONS; ACCURACY; STRATEGY
ISSN (print) / ISBN
0947-8965
e-ISSN
1433-0415
Journal
Onkologe, Der
Quellenangaben
Volume: 16,
Issue: 10,
Pages: 992-1002
Publisher
Springer
Publishing Place
New York
Non-patent literature
Publications
Reviewing status
Peer reviewed